Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS · Delayed Price · Currency is USD
0.0471
+0.0021 (4.74%)
At close: Dec 10, 2025
Enzon Pharmaceuticals Market Cap
Enzon Pharmaceuticals has a market cap or net worth of $3.5 million as of December 10, 2025. Its market cap has decreased by -47.63% in one year.
Market Cap
3.50M
Enterprise Value
4.32M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since January 16, 1990, Enzon Pharmaceuticals's market cap has decreased from 108.08M to 3.50M, a decrease of -96.76%. That is a compound annual growth rate of -9.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 3.34M | -71.17% |
| Dec 31, 2024 | 11.58M | 66.86% |
| Dec 29, 2023 | 6.94M | -62.07% |
| Dec 30, 2022 | 18.31M | -27.99% |
| Dec 31, 2021 | 25.42M | 37.89% |
| Dec 31, 2020 | 18.43M | 102.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 558.66M |
| Glass House Brands | 470.56M |
| CytoDyn | 410.11M |
| Northwest Biotherapeutics | 367.17M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 292.85M |
| Nika Pharmaceuticals | 259.91M |